drugset / Trial / NCT00139217
NO Need to Ventilate: A Trial of Non-invasive Inhaled Nitric Oxide in Persistent Pulmonary Hypertension of the Newborn
RandomizedSingle-groupOpen-labelTreatment
Summary
The primary objective of the trial is to determine the feasibility and clinical safety and efficacy of non-invasive inhaled nitric oxide in infants with PPHN without significant pulmonary +-parenchymal disease who would normally receive inhaled nitric oxide only after placement of a tracheal tube and the institution of mechanical ventilation.
Timeline
- Start
- 2005-08
- Primary completion
- 2007-09
- Completion
- 2007-09
Drugs
| Evaluation | Drug | Modality | Dose | Route |
|---|---|---|---|---|
| Subject | inhaled nitric oxide | Unknown | 10 ppm | Intranasal |
| Subject | inhaled nitric oxide | Unknown | 20 ppm | Intranasal |